AstraZeneca sues FDA over cholesterol drug

30-06-2016

AstraZeneca sues FDA over cholesterol drug

Sebra / Shutterstock.com

AstraZeneca has sued the US Food and Drug Administration (FDA), asking a court to prevent the FDA from approving any generic version of Crestor (rosuvastatin), which is due to expire on July 8 this year.


AstraZeneca, FDA, Crestor, patent, rosuvastatin, US Food and Drug Administration

LSIPR